Add to MyPages

This page will be saved to Cincinnati Children's MyPages, a collection of your favorite places. You can view, organize, or delete your favorites at any time.

 (optional)

E-mail this page

(All fields required)


Please enter a valid e-mail.

Please enter your name.

Please enter a valid e-mail.


Share this on:

Behavioral Medicine and Clinical Psychology

Significant Accomplishments

Successful Year for Grants  

Over the past 18 months, 68 percent of all grant applications submitted to the National Institutes of Health or foundations have been funded or received a fundable score. These successes are attributable to several factors. First, we have recruited and retained some of the most talented behavioral scientists in the country, all of whom have remained steadfast and persistent in grant submissions through these difficult funding times. Second, infrastructure investments into the grants office and the Divisional Data Core have promoted the level of support and innovation necessary to produce the most competitive applications. Finally, there is a commitment to the mentoring structure and to the peer review process such that every application is the product of multiple efforts and is injected with the collective expertise of all research faculty.     

Results Published from Key Juvenile Fibromyalgia Treatment Trial 

Susmita Kashikar-Zuck, PhD, recently completed a five-year multi-site randomized clinical trial funded by the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS) in which cognitive behavioral therapy (CBT) was found to be a safe, well-tolerated and effective intervention for reducing disability and depressive symptoms in the treatment of adolescents with juvenile fibromyalgia syndrome.  Effects were maintained six months after the treatment was completed, showing that the effects of treatment are durable.  This is the first rigorously controlled trial of CBT for pediatric patients with fibromyalgia and results will soon be published in the journal, Arthritis and Rheumatism. 

 Faculty Make Crucial Research Transitions 

 The transition from K-series career development awards to investigator-initiated R01 grants is an essential step for faculty to successfully establish scientific independence and to demonstrate sustainability for their research programs. Through preliminary and pilot studies generated from his K23 award, Kevin Hommel, PhD,developed a group-based treatment and an individually-tailored telehealth treatment for pediatric inflammatory bowel disease (IBD). Hommel was recently awarded an R01 grant from the NICHD that will examine the effect of these treatments on medication adherence, disease severity, health-related quality of life and health care utilization. Korey Hood, PhD, utilized a K23 award to document the prevalence and correlates of depression in adolescents with type 1 diabetes. This mix of diabetes and depression is dangerous given the negative impact of depression on disease management and health outcomes for adolescents. Hood was recently awarded an R01grant from the NIDDK to implement a preventive intervention designed to curtail depression and promote optimal health outcomes in this high-risk pediatric population.